BioHarvest Sciences Statistics
Want to see BHST full AI Analyst Report?
BioHarvest Sciences (BHST) Stock Statistics & Valuation Metrics
Total Valuation
BioHarvest Sciences has a market cap or net worth of $36.04M. The enterprise value is $66.16M.
- Market Cap
- $36.04M
- Enterprise Value
- $66.16M
Share Statistics
BioHarvest Sciences has 22,667,843 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 22,667,843
- Owned by Insiders
- ―
- Owned by Institutions
- 3.39%
Financial Efficiency
BioHarvest Sciences’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -13.42%.
- Return on Equity (ROE)
- -0.44
- Return on Assets (ROA)
- -0.23
- Return on Invested Capital (ROIC)
- -13.42%
- Return on Capital Employed (ROCE)
- -0.14
- Revenue Per Employee
- 387.73K
- Profits Per Employee
- -125.11K
- Employee Count
- 89
- Asset Turnover
- 0.72
- Inventory Turnover
- 3.08
Valuation Ratios
The current PE Ratio of BioHarvest Sciences is -3.24. BioHarvest Sciences’s PEG ratio is -0.12.
- PE Ratio
- -3.24
- PS Ratio
- 0.85
- PB Ratio
- 2.01
- Price to FCF
- -2.77
- Price to Operating Cash Flow
- -4.55
- PEG Ratio
- -0.12
Income Statement
In the last 12 months, BioHarvest Sciences had revenue of 34.51M and earned -11.13M in profits. Earnings per share was -0.60.
- Revenue
- 34.51M
- Gross Profit
- 20.48M
- Operating Income
- -5.58M
- Pretax Income
- -11.06M
- Net Income
- -11.13M
- EBITDA
- -6.71M
- Earnings Per Share (EPS)
- -0.60
Cash Flow
In the last 12 months, operating cash flow was -8.71M and capital expenditures -2.24M, giving a free cash flow of -10.95M billion.
- Operating Cash Flow
- -8.71M
- Free Cash Flow
- -10.95M
- Free Cash Flow per Share
- -0.48
Dividends & Yields
BioHarvest Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -36.11%
- Earnings Yield
- -27.91%
Stock Price Statistics
- Beta
- 1.15
- 52-Week Price Change
- -79.69%
- 50-Day Moving Average
- 1.66
- 200-Day Moving Average
- 3.12
- Relative Strength Index (RSI)
- 46.74
- Average Volume (3m)
- 32.28K
Important Dates
BioHarvest Sciences upcoming earnings date is Nov 12, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
BioHarvest Sciences as a current ratio of 3.97, with Debt / Equity ratio of 55.42%
- Current Ratio
- 3.97
- Quick Ratio
- 3.38
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- 1.33
- Interest Coverage Ratio
- -2.05
Taxes
In the past 12 months, BioHarvest Sciences has paid 76.00K in taxes.
- Income Tax
- 76.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
BioHarvest Sciences EV to EBITDA ratio is -4.34, with an EV/FCF ratio of -2.89.
- EV to Sales
- 0.89
- EV to EBITDA
- -4.34
- EV to Free Cash Flow
- -2.89
- EV to Operating Cash Flow
- -3.63
Balance Sheet
BioHarvest Sciences has $16.22M in cash and marketable securities with $17.55M in debt, giving a net cash position of -$1.33M billion.
- Cash & Marketable Securities
- $16.22M
- Total Debt
- $17.55M
- Net Cash
- -$1.33M
- Net Cash Per Share
- -$0.06
- Tangible Book Value Per Share
- $0.87
Margins
Gross margin is 58.95%, with operating margin of -17.99%, and net profit margin of -31.21%.
- Gross Margin
- 58.95%
- Operating Margin
- -17.99%
- Pretax Margin
- -30.94%
- Net Profit Margin
- -31.21%
- EBITDA Margin
- -20.55%
- EBIT Margin
- -25.45%
Analyst Forecast
The average price target for BioHarvest Sciences is $9.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $9.00
- Price Target Upside
- 466.04% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- 17.50%
- EPS Growth Forecast
- 24.63%
Scores
- Smart Score
- 4
- AI Score
- 42
